Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva's Budding Blockbusters Lend Respite From Legal Concerns
The Difficulties of Cloning a CEO - Bloomberg
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
US states accuse Teva and other drugmakers of colluding to inflate prices over 1,000%
Teva CEO Says Drugmaker Will Fight Price-Fixing Charges - Hamodia.com
Teva Pharmaeutical Stock Gets Upgrade From Analyst | Barron's
Teva Gets Generic Price-Fixing Securities Suits Consolidated
Teva, Allergan ready to pay $5B to settle thousands of opioid lawsuits (TEVA) | Seeking Alpha
Teva Wins Ruling Tossing $235 Million Glaxo Drug Verdict - Bloomberg
Teva Pharmaceuticals (TEVA) Stock Gets Upgraded at HSBC - TheStreet
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Teva Agrees to Stop Selling Amgen Generic Following Patent Infringement Settlement | Ctech
Teva CEO Has Doubts About Making Generic-Drug Ingredients in the U.S. | Barron's
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Cash-strapped Teva closes in on women's health sale No. 2: report | Fierce Pharma
Teva Abandons Search to Make Covid-19 Vaccine for Partners - Bloomberg
Israel's Teva offering free drugs to settle U.S. opiods case - Business - Haaretz.com
Teva's CEO Was $2.8 Billion Down on His Second Day on the Job - Bloomberg
How Uggs, Hoka, and Tevas Helped Build Deckers' $2.5 Billion Ugly-Shoe Empire - Bloomberg
Teva, Allergan Ready To Pay $5B To Settle Lawsuits Related To Opioid Painkillers: Bloomberg
Activist Investor Jana Partners Takes Stake in Teva, Report Says | Ctech
Teva (TEVA) Agrees to $225 Million Texas Opioid Settlement, AG Says - Bloomberg
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
